Cullinan Associates Inc. Trims Stock Position in Abbott Laboratories (NYSE:ABT)
Cullinan Associates Inc. trimmed its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 15.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 43,794 shares of the healthcare product maker’s stock after selling 7,700 shares during the period. Cullinan Associates Inc.’s holdings […]
25 Oct 13:04 · The Cerbat Gem